|
|
||||||||
1 From the Department of Ophthalmology and 2 Nikolaus-Fiebiger-Zentrum for Molecular Medicine, University of Erlangen-Nürnberg, Erlangen, Germany; the 3 Department of Clinical Pathology, University of Vienna, Vienna, Austria; the 4 Haartman Institute, Molecular and Cancer Biology Laboratory, University of Helsinki, Helsinki, Finland; and the 5 Medical Research Council Human Immunology Unit, Institute of Molecular Medicine, Oxford, United Kingdom.
PURPOSE. To determine whether lymphatic vessels exist in vascularized human corneas, by using immunohistochemistry with novel markers for lymphatic endothelium.
METHODS. Human corneas exhibiting neovascularization secondary to keratitis, transplant rejection, trauma, and limbal insufficiency (n = 21) were assessed for lymphatic vessel content by conventional transmission electron microscopy and by immunostaining and immunoelectron microscopy with antibodies specific for the lymphatic endothelial markers, lymphatic vessel endothelial hyaluronan receptor (LYVE-1) and the 38-kDa integral membrane glycoprotein podoplanin. In addition, corneas were stained for the lymphangiogenic growth factor VEGF-C, and its receptor VEGFR3 by immunohistochemistry and in situ RNA hybridization, respectively.
RESULTS. Thin-walled, erythrocyte-free vessels staining with lymphatic markers (LYVE-1 and podoplanin) were found to constitute 8% of all vessels, to be more common in the early course of neovascularization, to be always associated with blood vessels and stromal inflammatory cells, and to correlate significantly with the degree of corneal hemangiogenesis (r = 0.6; P = 0.005). VEGF-C, VEGFR3, podoplanin, and LYVE-1 colocalized on the endothelial lining of lymphatic vessels. With immunogold labeling, LYVE-1 and podoplanin antigen were found on endothelial cells lining vessels with ultrastructural features of lymph vessels.
CONCLUSIONS. Immunohistochemistry with novel lymph-endothelium markers and ultrastructural analyses indicate the existence of lymphatic vessels in vascularized human corneas. Human corneal lymphangiogenesis appears to be correlated with the degree of corneal hemangiogenesis and may at least partially be mediated by VEGF-C and its receptor VEGFR3.
This article has been cited by other articles:
![]() |
L. M. Heindl, C. Hofmann-Rummelt, U. Schlotzer-Schrehardt, F. E. Kruse, and C. Cursiefen Histologic Analysis of Descemet Stripping in Posterior Lamellar Keratoplasty Arch Ophthalmol, April 1, 2008; 126(4): 461 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Bachmann, F. Bock, S. J. Wiegand, K. Maruyama, M. R. Dana, F. E. Kruse, E. Luetjen-Drecoll, and C. Cursiefen Promotion of Graft Survival by Vascular Endothelial Growth Factor A Neutralization After High-Risk Corneal Transplantation Arch Ophthalmol, January 1, 2008; 126(1): 71 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dietrich, J. Onderka, F. Bock, F. E. Kruse, D. Vossmeyer, R. Stragies, G. Zahn, and C. Cursiefen Inhibition of Inflammatory Lymphangiogenesis by Integrin {alpha}5 Blockade Am. J. Pathol., July 1, 2007; 171(1): 361 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, M. Chen, D. M. Reid, and J. V. Forrester LYVE-1-Positive Macrophages Are Present in Normal Murine Eyes Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2162 - 2171. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Maruyama, J. Asai, M. Ii, T. Thorne, D. W. Losordo, and P. A. D'Amore Decreased Macrophage Number and Activation Lead to Reduced Lymphatic Vessel Formation and Contribute to Impaired Diabetic Wound Healing Am. J. Pathol., April 1, 2007; 170(4): 1178 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cursiefen, L. Chen, M. Saint-Geniez, P. Hamrah, Y. Jin, S. Rashid, B. Pytowski, K. Persaud, Y. Wu, J. W. Streilein, et al. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision PNAS, July 25, 2006; 103(30): 11405 - 11410. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Religa, R. Cao, M. Bjorndahl, Z. Zhou, Z. Zhu, and Y. Cao Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels Blood, December 15, 2005; 106(13): 4184 - 4190. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, C. Cursiefen, S. Barabino, Q. Zhang, and M. R. Dana Novel Expression and Characterization of Lymphatic Vessel Endothelial Hyaluronate Receptor 1 (LYVE-1) by Conjunctival Cells Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4536 - 4540. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Klebe, D. J. Coster, P. J. Sykes, S. Swinburne, P. Hallsworth, J.-P. Y. Scheerlinck, R. Krishnan, and K. A. Williams Prolongation of Sheep Corneal Allograft Survival by Transfer of the Gene Encoding Ovine IL-12-p40 but Not IL-4 to Donor Corneal Endothelium J. Immunol., August 15, 2005; 175(4): 2219 - 2226. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cursiefen, S. Ikeda, P. M. Nishina, R. S. Smith, A. Ikeda, D. Jackson, J.-S. Mo, L. Chen, M. R. Dana, B. Pytowski, et al. Spontaneous Corneal Hem- and Lymphangiogenesis in Mice with Destrin-Mutation Depend on VEGFR3 Signaling Am. J. Pathol., May 1, 2005; 166(5): 1367 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Chang, G. Garcia-Cardena, F. Farnebo, M. Fannon, E. J. Chen, C. Butterfield, M. A. Moses, R. C. Mulligan, J. Folkman, and A. Kaipainen Dose-dependent response of FGF-2 for lymphangiogenesis PNAS, August 10, 2004; 101(32): 11658 - 11663. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cursiefen, J. Cao, L. Chen, Y. Liu, K. Maruyama, D. Jackson, F. E. Kruse, S. J. Wiegand, M. R. Dana, and J. W. Streilein Inhibition of Hemangiogenesis and Lymphangiogenesis after Normal-Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2666 - 2673. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Dullforce, K. L. Garman, G. W. Seitz, R. J. Fleischmann, S. M. Crespo, S. R. Planck, D. C. Parker, and J. T. Rosenbaum APCs in the Anterior Uveal Tract Do Not Migrate to Draining Lymph Nodes J. Immunol., June 1, 2004; 172(11): 6701 - 6708. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cursiefen, S. Masli, T. F. Ng, M. R. Dana, P. Bornstein, J. Lawler, and J. W. Streilein Roles of Thrombospondin-1 and -2 in Regulating Corneal and Iris Angiogenesis Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1117 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Xu, J Edwards, S Banerji, R Prevo, D G Jackson, and N A Athanasou Distribution of lymphatic vessels in normal and arthritic human synovial tissues Ann Rheum Dis, December 1, 2003; 62(12): 1227 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schmidt-Erfurth, U. Schlotzer-Schrehard, C. Cursiefen, S. Michels, A. Beckendorf, and G. O. H. Naumann Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium-Derived Factor Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4473 - 4480. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hamrah, L. Chen, Q. Zhang, and M. R. Dana Novel Expression of Vascular Endothelial Growth Factor Receptor (VEGFR)-3 and VEGF-C on Corneal Dendritic Cells Am. J. Pathol., July 1, 2003; 163(1): 57 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Cursiefen, C Hofmann-Rummelt, M Kuchle, and U Schlotzer-Schrehardt Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation Br. J. Ophthalmol., January 1, 2003; 87(1): 101 - 106. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |